ArticleMOJ immunology2014

HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.

Will Dampier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.